Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionMBL Wealth, LLC
Latest Disclosed Ownership2,216 shares
Latest Disclosed Value $ 227,517
MBL Wealth, LLC reports 15.72% increase in ownership of ABL / Abbott Laboratories

On April 28, 2026 - MBL Wealth, LLC filed a 13F-HR form disclosing ownership of 2,216 shares of Abbott Laboratories (DE:ABL) valued at $196,825 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 1,915 shares of Abbott Laboratories. This represents a change in shares of 15.72% during the quarter. The current value of the position is $166,688 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 2,216 301 15.72 228 -5.02 0.0158
2026-01-21 2025-12-31 13F ABBOTT LABS COM 002824100 1,915 -406 -17.49 240 -22.90 0.0175
2025-10-16 2025-09-30 13F ABBOTT LABS COM 002824100 2,321 -49 -2.07 311 -3.73 0.0271
2025-07-22 2025-06-30 13F ABBOTT LABS COM 002824100 2,370 3 0.13 322 2.88 0.0308
2025-05-21 2025-03-31 13F ABBOTT LABS COM 002824100 2,367 2,367 314 0.0317
2024-07-19 2024-06-30 13F ABBOTT LABS COM 002824100 0 -2,590 -100.00 0 -100.00
2024-04-22 2024-03-31 13F ABBOTT LABS COM 002824100 2,590 86 3.43 294 6.91 0.0334
2024-01-18 2023-12-31 13F ABBOTT LABS COM 002824100 2,504 157 6.69 276 21.15 0.0345
2023-10-11 2023-09-30 13F ABBOTT LABS COM 002824100 2,347 2,347 227 0.0320
2023-07-17 2023-06-30 13F ABBOTT LABS COM 002824100 0 -2,157 -100.00 0 -100.00
2023-04-12 2023-03-31 13F ABBOTT LABS COM 002824100 2,157 -1,748 -44.76 218 0.0342
2023-01-12 2022-12-31 13F ABBOTT LABS COM 002824100 3,905 3,905 0 0.0820
2023-01-12 2022-09-30 13F ABBOTT LABS COM 002824100 0 -1,922 -100.00 0 -100.00
2023-01-12 2022-06-30 13F ABBOTT LABS COM 002824100 1,922 -1,365 -41.53 209 -46.27 0.0521
2022-05-02 2022-03-31 13F ABBOTT LABS COM 002824100 3,287 3,287 389 0.0949
2021-10-25 2021-09-30 13F ABBOTT LABS COM 002824100 0 -3,133 -100.00 0 -100.00
2021-05-27 2021-03-31 13F ABBOTT LABS COM 002824100 3,133 -7 -0.22 375 9.01 0.1308
2021-02-16 2020-12-31 13F ABBOTT LABORATORIES COM 002824100 3,140 3,140 344 0.1362
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.